{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T10:55:27Z","timestamp":1775559327783,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,7]]},"DOI":"10.7759\/cureus.106568","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:59:43Z","timestamp":1775555983000},"source":"Crossref","is-referenced-by-count":0,"title":["The Association Between Serum Nesfatin-1 Levels and Metabolic Parameters in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Shubhangi","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharti","family":"Kawatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harpreet K","family":"Walia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale HF","year":"2018","unstructured":"Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018, 14:270-84. 10.1038\/nrendo.2018.24","journal-title":"Nat Rev Endocrinol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis E","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012, 33:981-1030. 10.1210\/er.2011-1034","journal-title":"Endocr Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls","volume":"3","author":"Witchel SF","year":"2019","unstructured":"Witchel SF, Oberfield SE, Pe\u00f1a AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc. 2019, 3:1545-73. 10.1210\/js.2019-00078","journal-title":"J Endocr Soc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.18.6.0318","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif A","year":"1997","unstructured":"Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997, 18:774-800. 10.1210\/edrv.18.6.0318","journal-title":"Endocr Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004, 19:41-7. 10.1093\/humrep\/deh098","journal-title":"Hum Reprod"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nature05162","article-title":"Identification of nesfatin-1 as a satiety molecule in the hypothalamus","volume":"443","author":"Oh-I S","year":"2006","unstructured":"Oh-I S, Shimizu H, Satoh T, et al.. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 2006, 443:709-12. 10.1038\/nature05162","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2010.05.002","article-title":"Nesfatin-1--role as possible new potent regulator of food intake","volume":"163","author":"Stengel A","year":"2010","unstructured":"Stengel A, Tach\u00e9 Y. Nesfatin-1--role as possible new potent regulator of food intake. Regul Pept. 2010, 163:18-23. 10.1016\/j.regpep.2010.05.002","journal-title":"Regul Pept"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.k11e-056","article-title":"Nesfatin-1 enhances glucose-induced insulin secretion by promoting Ca(2+) influx through L-type channels in mouse islet \u03b2-cells","volume":"58","author":"Nakata M","year":"2011","unstructured":"Nakata M, Manaka K, Yamamoto S, Mori M, Yada T. Nesfatin-1 enhances glucose-induced insulin secretion by promoting Ca(2+) influx through L-type channels in mouse islet \u03b2-cells. Endocr J. 2011, 58:305-13. 10.1507\/endocrj.k11e-056","journal-title":"Endocr J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-1471","article-title":"Nutrient responsive nesfatin-1 regulates energy balance and induces glucose-stimulated insulin secretion in rats","volume":"152","author":"Gonzalez R","year":"2011","unstructured":"Gonzalez R, Perry RL, Gao X, Gaidhu MP, Tsushima RG, Ceddia RB, Unniappan S. Nutrient responsive nesfatin-1 regulates energy balance and induces glucose-stimulated insulin secretion in rats. Endocrinology. 2011, 152:3628-37. 10.1210\/en.2010-1471","journal-title":"Endocrinology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-012-9638-7","article-title":"Nesfatin-1 and other hormone alterations in polycystic ovary syndrome","volume":"42","author":"Deniz R","year":"2012","unstructured":"Deniz R, Gurates B, Aydin S, et al.. Nesfatin-1 and other hormone alterations in polycystic ovary syndrome. Endocrine. 2012, 42:694-9. 10.1007\/s12020-012-9638-7","journal-title":"Endocrine"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2015.1024219","article-title":"Nesfatin-1 levels and metabolic markers in polycystic ovary syndrome","volume":"31","author":"Alp E","year":"2015","unstructured":"Alp E, G\u00f6rm\u00fc\u015f U, G\u00fcd\u00fcc\u00fc N, Bozkurt S. Nesfatin-1 levels and metabolic markers in polycystic ovary syndrome. Gynecol Endocrinol. 2015, 31:543-7. 10.3109\/09513590.2015.1024219","journal-title":"Gynecol Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12337","article-title":"Effects of correction of vitamin D insufficiency on serum osteocalcin and glucose metabolism in obese children","volume":"80","author":"Poomthavorn P","year":"2014","unstructured":"Poomthavorn P, Nantarakchaikul P, Mahachoklertwattana P, Chailurkit LO, Khlairit P. Effects of correction of vitamin D insufficiency on serum osteocalcin and glucose metabolism in obese children. Clin Endocrinol (Oxf). 2014, 80:516-23. 10.1111\/cen.12337","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7176.116232","article-title":"How to calculate sample size for different study designs in medical research?","volume":"35","author":"Charan J","year":"2013","unstructured":"Charan J, Biswas T. How to calculate sample size for different study designs in medical research?. Indian J Psychol Med. 2013, 35:121-6. 10.4103\/0253-7176.116232","journal-title":"Indian J Psychol Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/0019-2791(71)90454-X","article-title":"Enzyme-linked immunosorbent assay (ELISA): quantitative assay of immunoglobulin G","volume":"8","author":"Engvall E","year":"1971","unstructured":"Engvall E, Perlmann P. Enzyme-linked immunosorbent assay (ELISA): quantitative assay of immunoglobulin G. Immunochemistry. 1971, 8:871-4. 10.1016\/0019-2791(71)90454-X","journal-title":"Immunochemistry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/476212-the-association-between-serum-nesfatin-1-levels-and-metabolic-parameters-in-women-with-polycystic-ovary-syndrome-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:59:44Z","timestamp":1775555984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/476212-the-association-between-serum-nesfatin-1-levels-and-metabolic-parameters-in-women-with-polycystic-ovary-syndrome-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.106568","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,7]]}}}